Cargando…
Pentraxin-3 as a Marker of both the Presence and the Severity of Metabolic Syndrome
Autores principales: | Canpolat, Uğur, Turak, Osman, Tok, Derya, Çağlı, Kumral, Aydoğdu, Sinan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586886/ https://www.ncbi.nlm.nih.gov/pubmed/24504179 http://dx.doi.org/10.1159/000358222 |
Ejemplares similares
-
Clinical Outcomes and Inflammatory Markers Should Be Kept in Mind when Assessing the Mean Platelet Volume in Patients with Infective Endocarditis
por: Canpolat, Uğur, et al.
Publicado: (2014) -
Electrocardiographic data should be coupled with tissue-Doppler imaging and clinical follow-up evaluation to determine cardiac involvement in lichen planus
por: Canpolat, Uğur, et al.
Publicado: (2013) -
The Yin and Yang of dyspnea in the emergency department: heart failure or COPD?
por: Canpolat, Uğur, et al.
Publicado: (2013) -
Killing Two Birds with One Stone: Screening of Coronary Artery Disease and Cardiac Autonomic Dysfunction in Psoriasis
por: Canpolat, Uğur, et al.
Publicado: (2014) -
Impact of free thyroxine levels and other clinical factors on bare metal stent restenosis
por: Canpolat, Uğur, et al.
Publicado: (2016)